Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Amarin is my Italian Sports Car/60's English Motorcycle. Aurinia is my grocery getter. Time spent and hopes crushed vs a reliable performer.
Back to concentrating on AMRN......
$AUPH New 2yr Benlysta data confirms Lupkynis is far superior. Benlysta at 2yrs did not meet efficacy in the primary or secondary endpoint, no matter how $GSK is trying to spin it. It failed. #Lupkynis is the new standard of care.
— AH33 (@AHimar33) October 19, 2021
This is like the time the voices in my head decided to give each other the silent treatment.
Or like the other stock boards on iHub that go days without a post.
Sounds of silence.
I hope it is the whisper of the snowfall that leads to the Avalanche....
Made an impression, did it?
Surprised this hasn't got more discussion here...
This seems something to promote...
https://amarincorp.com/docs/Formulary_Status.pdf
Just look at all the calls out for January 21 st of which I own a bunch of $5 at aprox $1 each SO SAD !!!
A year ago it was a good bet. Here's hoping...
$NNOX CEO reduces stake, will leave in Jan
— TerraPharma (@TerraPharma1) September 30, 2021
Today Ran has 3,278,368 shares (Consists of 2,823,389 ordinary shares & options to purchase 454,979 ordinary shares within 60 days of Sept 30 2021)
At start of 2021 Ran owned 4,806,120 shares (Shares +shares exercisable within 60 days) pic.twitter.com/s3fGbYiCmB